Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation.

作者: Hylton V. Joffe , Gail K. Adler

DOI: 10.1007/S10741-005-2346-0

关键词:

摘要: Aldosterone, the final product of renin-angiotensin-aldosterone system, is classically viewed as a regulator renal sodium and potassium handling, blood volume, pressure. Recent studies suggest that aldosterone can cause microvascular damage, vascular inflammation, oxidative stress endothelial dysfunction. In animal models, aldosterone-mediated injury in brain, heart, kidneys leads to stroke, myocardial injury, proteinuria. These effects may be modified by dietary salt intake; damage increased susceptible animals fed high-salt diet compared low-salt despite lower plasma levels on diet. humans, there growing literature supporting adverse heart failure, hypertension, left ventricular hypertrophy, disease. Aldosterone receptor antagonists are beneficial even patients angiotensin converting enzyme inhibitors attenuate mechanisms appear independent changes systolic This review focuses system describes our current understanding underlying for this injury.

参考文章(41)
Johann Bauersachs, Marina Heck, Daniela Fraccarollo, Steven K Hildemann, Georg Ertl, Martin Wehling, Michael Christ, Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. Journal of the American College of Cardiology. ,vol. 39, pp. 351- 358 ,(2002) , 10.1016/S0735-1097(01)01729-6
Yao Sun, Jiakun Zhang, Li Lu, Sue S. Chen, Mark T. Quinn, Karl T. Weber, Aldosterone-Induced Inflammation in the Rat Heart: Role of Oxidative Stress American Journal of Pathology. ,vol. 161, pp. 1773- 1781 ,(2002) , 10.1016/S0002-9440(10)64454-9
Dominik Behrendt, Peter Ganz, Endothelial function. From vascular biology to clinical applications. American Journal of Cardiology. ,vol. 90, ,(2002) , 10.1016/S0002-9149(02)02963-6
Shuji Arima, Kentaro Kohagura, Hong-Lan Xu, Akira Sugawara, Akira Uruno, Fumitoshi Satoh, Kazuhisa Takeuchi, Sadayoshi Ito, Endothelium-Derived Nitric Oxide Modulates Vascular Action of Aldosterone in Renal Arteriole Hypertension. ,vol. 43, pp. 352- 357 ,(2004) , 10.1161/01.HYP.0000111138.78714.1A
Nancy J. Brown, Kyung-Soo Kim, Yan-Qun Chen, Lewis S. Blevins, John H. Nadeau, Steven G. Meranze, Douglas E. Vaughan, Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production. The Journal of Clinical Endocrinology and Metabolism. ,vol. 85, pp. 336- 344 ,(2000) , 10.1210/JCEM.85.1.6305
Shlomo Keidar, Tony Hayek, Marielle Kaplan, Elsa Pavlotzky, Shadi Hamoud, Raymond Coleman, Michael Aviram, Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice. Journal of Cardiovascular Pharmacology. ,vol. 41, pp. 955- 963 ,(2003) , 10.1097/00005344-200306000-00019
Makoto Katoh, Kensuke Egashira, Takashi Mitsui, Susumu Chishima, Akira Takeshita, Hiroshi Narita, Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis. Journal of Molecular and Cellular Cardiology. ,vol. 32, pp. 73- 83 ,(2000) , 10.1006/JMCC.1999.1053
Victor J. Dzau, Kenneth Bernstein, David Celermajer, Jerome Cohen, Björn Dahlöf, John Deanfield, Javier Diez, Helmut Drexler, Roberto Ferrari, Wiek van Gilst, Lennart Hansson, Burkhard Hornig, Ahsan Husain, Colin Johnston, Harold Lazar, Eva Lonn, Thomas Lüscher, John Mancini, Albert Mimran, Carl Pepine, Ton Rabelink, Willem Remme, Luis Ruilope, Marcel Ruzicka, Heribert Schunkert, Karl Swedberg, Thomas Unger, Douglas Vaughan, Michael Weber, The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data The American Journal of Cardiology. ,vol. 88, pp. 1- 20 ,(2001) , 10.1016/S0002-9149(01)01878-1